文献速递系统性红斑狼疮

2019 EULAR/ACR 狼疮标准在 LUMINA 多民族队列中的表现

Applying the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Lupus Criteria to Patients From the LUMINA Cohort: Results From the Multiethnic, Multicenter US Cohort.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-09-01

该研究在 LUMINA 多民族多中心队列中评估 2019 EULAR/ACR 狼疮分类标准相较 1982/1997 ACR 和 2012 SLICC 标准能否更早分类 SLE。结果显示 2019 EULAR/ACR 标准使 13.3% 患者较 ACR 标准提前分类(平均 0.66 年),15.3% 患者较 SLICC 标准提前分类(平均 0.63 年);较晚满足 2019 EULAR/ACR 标准的患者疾病活动度较低、anti-dsDNA 和 anti-Sm 阳性及狼疮肾炎 II 或 V 型较少,而黏膜皮肤表现、浆膜炎、白细胞减少和抗磷脂抗体阳性较多。

要点

  • 2019 EULAR/ACR 标准较 ACR 标准使 13.3% 患者提前分类,平均提前 0.66 年。
  • 2019 EULAR/ACR 标准较 SLICC 标准使 15.3% 患者提前分类,平均提前 0.63 年。
  • 较晚满足 2019 EULAR/ACR 标准的患者疾病活动度较低,但可识别出部分更严重疾病患者。

核心结论

  • 2019 EULAR/ACR 标准在真实临床实践中仅使相对小部分 SLE 患者较 ACR 或 SLICC 标准更早分类,但可提前分类部分疾病更严重的患者。

研究设计与样本

  • 研究纳入 LUMINA 多民族多中心队列中按 1982/1997 ACR 标准定义 SLE 的患者,比较 2019 EULAR/ACR 与 1982/1997 ACR 及 2012 SLICC 标准的时间分类。

主要发现

  • 2019 EULAR/ACR 标准较 1982/1997 ACR 标准使 13.3% 患者提前分类,平均提前 0.66 年。
  • 2019 EULAR/ACR 标准较 2012 SLICC 标准使 15.3% 患者提前分类,平均提前 0.63 年。
  • 较晚满足 2019 EULAR/ACR 标准(相较 ACR 标准)的患者疾病活动度较低,anti-dsDNA 和 anti-Sm 阳性及狼疮肾炎 II 或 V 型较少。
  • 较晚满足 2019 EULAR/ACR 标准(相较 ACR 标准)的患者更常见黏膜皮肤表现、浆膜炎、白细胞减少和抗磷脂抗体阳性。
  • 上述差异在与 2012 SLICC 标准比较时较不明显。

临床怎么用

  • 在临床实践中,2019 EULAR/ACR 标准可帮助早期分类部分 SLE 患者,尤其是疾病更严重者,但整体提前分类比例有限。

局限性

  • 研究基于按 1982/1997 ACR 标准定义 SLE 的 LUMINA 队列,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the performance of the 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) criteria for systemic lupus erythematosus (SLE) in terms of earlier SLE classification in comparison to the ACR or the Systemic Lupus International Collaborating Clinics (SLICC) criteria. METHODS: Patients from a multiethnic, multicenter cohort, the Lupus in Minorities: Nature versus Nurture cohort, where SLE was defined using the 1982/1997 ACR criteria were included. Demographic, clinical, and immunologic criteria were compared among the 2019 EULAR/ACR and the 1982/1997 ACR and the 2012 SLICC timing categories. RESULTS: The 2019 EULAR/ACR criteria allowed an earlier SLE classification in 13.3% of patients (mean 0.66 years) and 15.3% of patients (mean 0.63 years) compared to the 1982/1997 ACR and the 2012 SLICC criteria, respectively. Patients accruing the 2019 EULAR/ACR criteria later than the 1982/1997 ACR criteria had a lower disease activity, were less likely to have positivity to anti-double-stranded DNA and anti-Sm, as well as lupus nephritis classes II or V; they were more likely to have mucocutaneous manifestations, serositis, leukopenia, and antiphospholipid antibodies positivity. These differences were less pronounced when compared to the 2012 SLICC criteria CONCLUSION: The 2019 EULAR/ACR criteria classified SLE patients earlier than the 2 other criteria sets in real-life clinical practice scenarios in a relatively small proportion of the patients. However, these criteria could allow earlier classification of a subset of patients with a more severe disease.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Ugarte-Gil MF, Pons-Estel GJ, Harvey GB, et al. Applying the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Lupus Criteria to Patients From the LUMINA Cohort: Results From the Multiethnic, Multicenter US Cohort. Arthritis Care Res (Hoboken). 2021. PMID: 32598552. doi:10.1002/acr.24367

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。